Variant report

Variant	nsv979404
Chromosome Location	chr20:23429655-23455778
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr20:23440154-23440332	GM12878	blood:	n/a	chr20:23440243-23440254
2	BRCA1	chr20:23454055-23454315	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr20:23435864-23436154	IMR90	lung:	n/a	chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436004-23436015 chr20:23436006-23436015 chr20:23436005-23436016
4	CEBPB	chr20:23431788-23431941	HepG2	liver:	n/a	chr20:23431854-23431867 chr20:23431854-23431865 chr20:23431856-23431867
5	CEBPB	chr20:23435843-23436158	HepG2	liver:	n/a	chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436004-23436015 chr20:23436006-23436015 chr20:23436005-23436016
6	CEBPB	chr20:23435874-23436147	A549	lung:	n/a	chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436004-23436015 chr20:23436006-23436015 chr20:23436005-23436016
7	CEBPB	chr20:23435881-23436117	K562	blood:	n/a	chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436006-23436015 chr20:23436004-23436015 chr20:23436006-23436015 chr20:23436005-23436016
8	CTCF	chr20:23434919-23435019	GM19239	blood:	n/a	n/a
9	CTCF	chr20:23450995-23451019	Lung_OC	lung:	n/a	n/a
10	CTCF	chr20:23449500-23449650	GM12867	blood:	n/a	n/a
11	CTCF	chr20:23441714-23441754	GM13976	blood:	n/a	n/a
12	CTCF	chr20:23432900-23433050	A549	lung:	n/a	n/a
13	CTCF	chr20:23450596-23450634	GM13977	blood:	n/a	n/a
14	CTCF	chr20:23455380-23455410	Spleen_OC	spleen:	n/a	n/a
15	CTCF	chr20:23449330-23449381	GM13976	blood:	n/a	n/a
16	E2F6	chr20:23433853-23434137	H1-hESC	embryonic stem cell:	n/a	n/a
17	EBF1	chr20:23438445-23438681	GM12878	blood:	n/a	chr20:23438575-23438586
18	EBF1	chr20:23438441-23438683	GM12878	blood:	n/a	chr20:23438575-23438586
19	EBF1	chr20:23439759-23440051	GM12878	blood:	n/a	chr20:23439887-23439898 chr20:23439888-23439897 chr20:23439888-23439897 chr20:23439886-23439899
20	EP300	chr20:23453869-23454278	H1-hESC	embryonic stem cell:	n/a	n/a
21	FOS	chr20:23435845-23436043	MCF10A-Er-Src	breast:	n/a	chr20:23435970-23435978 chr20:23435968-23435980 chr20:23435971-23435982
22	FOS	chr20:23441800-23442103	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr20:23441800-23442116	MCF10A-Er-Src	breast:	n/a	n/a
24	FOS	chr20:23440112-23440387	MCF10A-Er-Src	breast:	n/a	chr20:23440244-23440255 chr20:23440243-23440251 chr20:23440241-23440253
25	FOS	chr20:23441852-23442083	MCF10A-Er-Src	breast:	n/a	n/a
26	FOS	chr20:23440119-23440327	MCF10A-Er-Src	breast:	n/a	chr20:23440244-23440255 chr20:23440243-23440251 chr20:23440241-23440253
27	FOS	chr20:23440104-23440424	MCF10A-Er-Src	breast:	n/a	chr20:23440244-23440255 chr20:23440243-23440251 chr20:23440241-23440253
28	FOS	chr20:23440111-23440327	MCF10A-Er-Src	breast:	n/a	chr20:23440244-23440255 chr20:23440243-23440251 chr20:23440241-23440253
29	FOS	chr20:23441864-23442081	MCF10A-Er-Src	breast:	n/a	n/a
30	GATA2	chr20:23452695-23452980	SH-SY5Y	brain:	n/a	n/a
31	GATA3	chr20:23429353-23429660	T-47D	breast:	n/a	n/a
32	GATA3	chr20:23452749-23452950	SH-SY5Y	brain:	n/a	n/a
33	JUND	chr20:23430176-23430308	K562	blood:	n/a	chr20:23430253-23430262
34	MAFF	chr20:23435446-23435817	HepG2	liver:	n/a	chr20:23435619-23435637
35	MAFF	chr20:23435467-23435798	K562	blood:	n/a	chr20:23435619-23435637
36	MAFF	chr20:23454727-23454934	HepG2	liver:	n/a	chr20:23454798-23454816
37	MAFF	chr20:23454725-23454925	K562	blood:	n/a	chr20:23454798-23454816
38	MAFK	chr20:23435475-23435715	H1-hESC	embryonic stem cell:	n/a	chr20:23435621-23435636
39	MAFK	chr20:23454630-23454930	HepG2	liver:	n/a	chr20:23454799-23454814
40	MAFK	chr20:23444192-23444444	HepG2	liver:	n/a	chr20:23444297-23444312
41	MAFK	chr20:23435455-23435801	HepG2	liver:	n/a	chr20:23435621-23435636
42	MAFK	chr20:23444256-23444385	IMR90	lung:	n/a	chr20:23444297-23444312
43	MAFK	chr20:23453884-23454135	H1-hESC	embryonic stem cell:	n/a	n/a
44	MAFK	chr20:23435495-23435762	K562	blood:	n/a	chr20:23435621-23435636
45	MAFK	chr20:23435442-23435820	HepG2	liver:	n/a	chr20:23435621-23435636
46	MAFK	chr20:23444214-23444429	HepG2	liver:	n/a	chr20:23444297-23444312
47	MAFK	chr20:23454633-23454952	HepG2	liver:	n/a	chr20:23454799-23454814
48	MAFK	chr20:23435451-23435807	IMR90	lung:	n/a	chr20:23435621-23435636
49	MAZ	chr20:23439273-23439353	GM12878	blood:	n/a	n/a
50	MYC	chr20:23440754-23440871	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:23434244-23434294	AG09309	skin:	n/a
2	chr20:23434244-23434294	AG09309	skin:	n/a
3	chr20:23432977-23433027	Caco-2	colon:	n/a
4	chr20:23434086-23434136	HRE	kidney:	n/a
5	chr20:23433608-23433658	H1-hESC	embryonic stem cell:	embryo
6	chr20:23431120-23431170	HepG2	liver:	n/a
7	chr20:23434244-23434294	GM06990	blood:	n/a
8	chr20:23431120-23431170	GM19239	blood:	n/a
9	chr20:23433349-23433399	ECC-1	luminal epithelium:	n/a
10	chr20:23433503-23433553	K562	blood:	n/a
11	chr20:23433608-23433658	NB4	blood:	n/a
12	chr20:23434279-23434329	AG04450	lung:	fetal
13	chr20:23431120-23431170	GM12891	blood:	n/a
14	chr20:23434244-23434294	ovcar-3	ovarian:	n/a
15	chr20:23432977-23433027	HNPCEpiC	eye:	n/a
16	chr20:23434244-23434294	MCF-7	breast:	n/a
17	chr20:23433608-23433658	ovcar-3	ovarian:	n/a
18	chr20:23432977-23433027	HepG2	liver:	n/a
19	chr20:23434279-23434329	AoSMC	blood vessel:	n/a
20	chr20:23434086-23434136	A549	lung:	n/a
21	chr20:23433349-23433399	Caco-2	colon:	n/a
22	chr20:23432977-23433027	GM12891	blood:	n/a
23	chr20:23434086-23434136	HepG2	liver:	n/a
24	chr20:23434279-23434329	ovcar-3	ovarian:	n/a
25	chr20:23434244-23434294	HRE	kidney:	n/a
26	chr20:23433608-23433658	Hepatocyte	liver:	n/a
27	chr20:23433503-23433553	GM12891	blood:	n/a
28	chr20:23432977-23433027	LNCaP	prostate:	n/a
29	chr20:23434279-23434329	PFSK-1	brain:	n/a
30	chr20:23431120-23431170	NB4	blood:	n/a
31	chr20:23433608-23433658	HNPCEpiC	eye:	n/a
32	chr20:23433349-23433399	PANC-1	pancreas:	n/a
33	chr20:23433503-23433553	RPTEC	kidney:	n/a
34	chr20:23434086-23434136	HMEC	breast:	n/a
35	chr20:23434086-23434136	SK-N-SH	brain:	n/a
36	chr20:23434279-23434329	HAEpiC	amniotic membrane:	n/a
37	chr20:23431120-23431170	AG04449	skin:	fetal
38	chr20:23434244-23434294	AoSMC	blood vessel:	n/a
39	chr20:23433349-23433399	LNCaP	prostate:	n/a
40	chr20:23434244-23434294	ECC-1	luminal epithelium:	n/a
41	chr20:23434279-23434329	HL-60	blood:	n/a
42	chr20:23434086-23434136	SKMC	muscle:	n/a
43	chr20:23433503-23433553	HCF	heart:	n/a
44	chr20:23433349-23433399	NB4	blood:	n/a
45	chr20:23432977-23433027	ProgFib	skin:	n/a
46	chr20:23434244-23434294	BJ	skin:	n/a
47	chr20:23431120-23431170	HRCEpiC	kidney:	n/a
48	chr20:23434244-23434294	ProgFib	skin:	n/a
49	chr20:23433503-23433553	IMR90	lung:	fetal
50	chr20:23432977-23433027	NHBE	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr20:23435629..23437264-chr20:23438674..23441153,2	MCF-7	breast:
2	chr20:23427640..23430149-chr20:23434541..23436355,2	MCF-7	breast:
3	chr20:23427640..23430149-chr20:23434541..23436355,2	MCF-7	breast:
4	chr20:23428863..23430535-chr20:23433558..23435826,2	K562	blood:
5	chr20:23435629..23437264-chr20:23438674..23441153,2	MCF-7	breast:
6	chr20:23429806..23432217-chr20:23436004..23438997,2	K562	blood:
7	chr20:23428863..23430535-chr20:23433558..23435826,2	K562	blood:
8	chr20:23434496..23436579-chr20:23437423..23440853,3	K562	blood:
9	chr20:23430353..23432292-chr20:23432999..23435596,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000200208	TF binding region
CST11	TF binding region
CST12P	TF binding region
ENSG00000200208	CpG island
CST11	CpG island
CST12P	CpG island
ENSG00000200208	chromatin interactions
ENSG00000125831	chromatin interactions

Extended variants
information (count: 1156 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:1156 , 50 per page) page: 1 2 3 4 5 6 7 ... 24

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs544726924	chr20:23429655-23429656	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs6048800	chr20:23429676-23429677	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs185524624	chr20:23429685-23429686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs543836170	chr20:23429719-23429720	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs561246083	chr20:23429720-23429721	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs146127462	chr20:23429752-23429753	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs547121669	chr20:23429772-23429773	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs566971799	chr20:23429804-23429805	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs190286579	chr20:23429829-23429830	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs552686913	chr20:23429831-23429832	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs6048801	chr20:23429862-23429863	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs538238514	chr20:23429878-23429879	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs555042668	chr20:23429880-23429881	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs562778286	chr20:23429887-23429888	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs148792845	chr20:23429922-23429923	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs187666749	chr20:23429942-23429943	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs572969164	chr20:23429960-23429961	Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs544839525	chr20:23430001-23430002	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs369214188	chr20:23430002-23430003	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs577983455	chr20:23430026-23430027	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs201689303	chr20:23430034-23430035	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs558211535	chr20:23430039-23430040	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs575044346	chr20:23430048-23430049	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs193231385	chr20:23430059-23430060	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs150930897	chr20:23430097-23430098	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
26	rs184038533	chr20:23430102-23430103	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs140744947	chr20:23430138-23430139	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs11908625	chr20:23430230-23430231	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs376407405	chr20:23430284-23430285	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs144211953	chr20:23430307-23430308	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
31	rs552850286	chr20:23430316-23430317	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
32	rs569364669	chr20:23430320-23430321	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
33	rs531851877	chr20:23430346-23430347	Weak transcription Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
34	rs527739000	chr20:23430461-23430462	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs6048802	chr20:23430467-23430468	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs2424559	chr20:23430519-23430520	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
37	rs541723396	chr20:23430544-23430545	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs561456594	chr20:23430548-23430549	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs141254678	chr20:23430558-23430559	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs188610885	chr20:23430641-23430642	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs192277153	chr20:23430645-23430646	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs184336912	chr20:23430704-23430705	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs11696116	chr20:23430730-23430731	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs112846882	chr20:23430732-23430733	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs146975029	chr20:23430733-23430734	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs537566907	chr20:23430786-23430787	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs551237814	chr20:23430793-23430794	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs561123167	chr20:23430813-23430814	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs554523896	chr20:23430829-23430830	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs531945255	chr20:23430848-23430849	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
small cell lung cancer	17426248	CNVD
Breast cancer	21364760	CNVD
Bipolar disorder	19114987	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:157 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:23417200-23434800	Weak transcription	Gastric	stomach
2	chr20:23417800-23441000	Weak transcription	Right Atrium	heart
3	chr20:23423000-23432200	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr20:23423800-23432200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr20:23427600-23429800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr20:23427800-23431600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
7	chr20:23429600-23431200	Enhancers	Fetal Thymus	thymus
8	chr20:23429800-23430000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
9	chr20:23429800-23430400	Enhancers	GM12878-XiMat	blood
10	chr20:23429800-23430600	Enhancers	Primary T cells fromperipheralblood	blood
11	chr20:23429800-23430600	Enhancers	Primary hematopoietic stem cells short term culture	blood
12	chr20:23429800-23430600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
13	chr20:23429800-23430600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
14	chr20:23430000-23430200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
15	chr20:23430000-23430400	Enhancers	Primary T killer naive cells fromperipheralblood	blood
16	chr20:23430000-23430400	Enhancers	Monocytes-CD14+_RO01746	blood
17	chr20:23430000-23430600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr20:23430000-23430600	Enhancers	Dnd41	blood
19	chr20:23430000-23430800	Enhancers	Primary T cells from cord blood	blood
20	chr20:23430200-23430400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
21	chr20:23430400-23436200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
22	chr20:23430600-23435200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
23	chr20:23430800-23432000	Weak transcription	Primary T cells from cord blood	blood
24	chr20:23431200-23434000	Weak transcription	Fetal Thymus	thymus
25	chr20:23431800-23432000	Enhancers	Pancreas	Pancrea
26	chr20:23431800-23432400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr20:23432000-23434600	Weak transcription	Pancreas	Pancrea
28	chr20:23432200-23432600	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr20:23432200-23432600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr20:23432400-23433400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
31	chr20:23432600-23432800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
32	chr20:23432600-23433400	Weak transcription	HUES6 Cell Line	embryonic stem cell
33	chr20:23432600-23433400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr20:23432600-23446000	Weak transcription	H9 Cell Line	embryonic stem cell
35	chr20:23432800-23433000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr20:23433200-23433800	Enhancers	Fetal Stomach	stomach
37	chr20:23433400-23433600	Bivalent Enhancer	Stomach Smooth Muscle	stomach
38	chr20:23433400-23433800	Enhancers	ES-I3 Cell Line	embryonic stem cell
39	chr20:23433400-23434000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr20:23433400-23434200	Enhancers	HUES6 Cell Line	embryonic stem cell
41	chr20:23433400-23434200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
42	chr20:23433600-23434000	Enhancers	H1 Cell Line	embryonic stem cell
43	chr20:23433800-23437000	Weak transcription	Fetal Stomach	stomach
44	chr20:23434000-23434200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
45	chr20:23434000-23434200	Genic enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
46	chr20:23434000-23434200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
47	chr20:23434000-23440400	Enhancers	Fetal Thymus	thymus
48	chr20:23434200-23434600	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
49	chr20:23434200-23434600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
50	chr20:23434200-23434600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links